INTERCEPT Fibrinogen Complex: Initial Experience at UF Health
Runtime: 14 min
Trauma, CV, and high-risk OB centers across the U.S. are implementing Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT Fibrinogen Complex or IFC), to ensure fibrinogen and other key clotting factors are ready to transfuse in the first minutes of hemorrhage treatment. In this symposium, Dr. Erin Vanzant will discuss the importance of early fibrinogen supplementation in traumatic hemorrhage, and how IFC’s 5-day post-thaw shelf life allows them to achieve this treatment goal while decreasing product waste, and improving blood availability for patients in need.
Erin Vanzant, MD
Associate Trauma Medical Director
Director of Transfusion Medicine Fellowship
UF Health Shands Hospital
Dr. Erin Vanzant earned her medical degree from the University of Texas School of Medicine at San Antonio and completed her general surgery residency training at the University of Florida College of Medicine where she was recognized as the Distinguished Resident Dedicated to Teaching. She also completed fellowships in surgical critical care and acute care surgery at the University of Florida.
She is a past, peer-selected member of the UF Health Department of Surgery Education/Program Evaluation Committee, as well as the Quality Improvement Committee. Dr. Vanzant has also completed multiple other training programs such as Advanced Surgical Skills for Exposure in Trauma and Advanced Trauma Life Support.
In 2013, Dr. Vanzant was the recipient of the Collaborative Research Forum Scholarship at the 5th Annual Collaborative Research Forum in Phoenix, Arizona. In the same year, she was awarded the Shock Society Travel Grant for New Investigators at the 37th Annual Conference on Shock in San Diego, California. She has delivered multiple presentations, her most recent being the Diagnosis and Management of Acute Pulmonary Embolism.
Watch the Replay
Runtime: 14 min